Daniel Joseph Apel
Chief Financial Officer · 1 filing · Latest: Apr 22, 2026
ARROWHEAD PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
ARWR | Daniel Joseph Apel | Chief Financial Officer | Apr 22, 2026 | Sale | $71.35 | 13,095 | $934.3K | 162,905 | |
ARWR | Daniel Apel | — | Apr 22, 2026 | Proposed Sale | $71.34 | 13,095 | $934.2K | — | |